ArticleAsian journal of pharmaceutical sciences2026
A barrier-crossing and immune checkpoint-blocking antibody fusion protein for enhanced glioma-targeted immunotherapy.
Yanning Bao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.